Market open· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
DocMorris AG (XSWX:DOCM) delivers 38% direct growth and record Rx revenue in Q2, prompting an upgraded full-year outlook despite one-off restructuring costs.
DocMorris AG (XSWX:DOCM) reports significant digital service expansion and strategic AI partnerships, while navigating financial hurdles and market uncertainties.
Key Insights DocMorris' significant retail investors ownership suggests that the key decisions are influenced by...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.